Correlation Between Exelixis and Vaxcyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Exelixis and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exelixis and Vaxcyte, you can compare the effects of market volatilities on Exelixis and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and Vaxcyte.

Diversification Opportunities for Exelixis and Vaxcyte

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Exelixis and Vaxcyte is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of Exelixis i.e., Exelixis and Vaxcyte go up and down completely randomly.

Pair Corralation between Exelixis and Vaxcyte

Given the investment horizon of 90 days Exelixis is expected to under-perform the Vaxcyte. But the stock apears to be less risky and, when comparing its historical volatility, Exelixis is 1.31 times less risky than Vaxcyte. The stock trades about -0.02 of its potential returns per unit of risk. The Vaxcyte is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  8,106  in Vaxcyte on November 9, 2024 and sell it today you would earn a total of  796.00  from holding Vaxcyte or generate 9.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Exelixis  vs.  Vaxcyte

 Performance 
       Timeline  
Exelixis 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Exelixis has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent technical and fundamental indicators, Exelixis is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.
Vaxcyte 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Vaxcyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Exelixis and Vaxcyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Exelixis and Vaxcyte

The main advantage of trading using opposite Exelixis and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.
The idea behind Exelixis and Vaxcyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Global Correlations
Find global opportunities by holding instruments from different markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities